Case | Age/gender | Disease condition | Pre-PET treatment | Involved organs/tissues detected by PET/CT | Post-PET treatment |
---|---|---|---|---|---|
1 | 56/M | Suspected recurrence | Resection | Paranasal sinus, nasopharynx and lymph node | Thalidomide and glucocorticoid |
2 | 33/M | Undiagnosed | – | Multiple intracranial lesions and lymph nodes | Resection, lenalidomide and glucocorticoid |
3 | 70/M | Suspected recurrence | Resection | Paranasal sinus, bilateral nasal cavity and laryngeal | Thalidomide |
4 | 28/F | Suspected recurrence | Biopsy, glucocorticoid | Bilateral cervical lymph nodes | Resection |
5 | 35/M | Newly diagnosed | Resection, glucocorticoid | Orbital apex and nasopharyngeal | Lenalidomide and glucocorticoid |
6 | 26/F | Suspected recurrence | Resection | Nasopharyngeal cavity, superior turbinate, subglottic nodule, subcutaneous nodules and lymph nodes | Lenalidomide and glucocorticoid |
7 | 11/M | Newly diagnosed | Biopsy | Pituitary, nasal cavity, nasopharyngeal and multiple bone lesions | Glucocorticoid |
8 | 22/M | Undiagnosed | – | Throat and lymph node | Resection and thalidomide |
9 | 57/M | Newly diagnosed | Resection | Nasal cavity, subglottic nodule and pituitary | Thalidomide |
10 | 48/F | Undiagnosed | – | Pulmonary trunk lumen, ascending aortic root wall and lymph nodes | Resection |
11 | 38/M | Newly diagnosed | Biopsy | Subcutaneous nodule | Resection |
12 | 27/F | Newly diagnosed | Resection | Lymph nodes | Observation |
13 | 21/F | Newly diagnosed | Resection | Nasal cavity, paranasal sinus, subcutaneous nodules and lymph nodes | Lenalidomide and glucocorticoid |
14 | 42/M | Newly diagnosed | Resection | Lacrimal gland, parotid gland, nasopharynx, pleura, pericardium, bone, subcutaneous nodules and lymph nodes | Lenalidomide and glucocorticoid |
15 | 37/M | Suspected recurrence | Biopsy, glucocorticoid | Multiple intracranial lesions | Cytarabine |
16 | 32/F | Suspected recurrence | Glucocorticoid | Parotid gland | Lenalidomide and glucocorticoid |
17 | 22/F | Newly diagnosed | Resection | No lesion | Observation |
18 | 51/F | Undiagnosed | – | Multiple bone lesions and lymph nodes | Lenalidomide and glucocorticoid |
19 | 70/M | Suspected recurrence | Resection, glucocorticoid, radiotherapy, immunosuppressor | Muscles, orbit, paranasal sinus, eyelids, plica vocalis and lymph nodes | Cytarabine |
20 | 33/F | Newly diagnosed | Biopsy | Nasal cavity, trachea, adrenal nodule, subcutaneous nodules and lymph nodes | Glucocorticoid |
21 | 53/M | Newly diagnosed | Biopsy | Multiple bone lesions, subcutaneous nodules and lymph nodes | Lenalidomide and glucocorticoid |
22 | 65/M | Undiagnosed | – | Multiple intracranial lesions, high-density tissue in T3-4 spinal canal, subcutaneous nodule and lymph nodes | Cytarabine |
23 | 63/F | Newly diagnosed | Resection, glucocorticoid, immunosuppressor | Muscles, bone lesion and subcutaneous nodules | Lenalidomide and glucocorticoid |
24 | 53/M | Suspected recurrence | Resection, glucocorticoid | Extraocular muscles, eyelids, lacrimal glands, parotid gland, laryngeal cavity and perirenal soft tissue | Lenalidomide and glucocorticoid |
25 | 60/M | Undiagnosed | – | Soft tissue in right atrium | Resection |
26 | 14/M | Suspected recurrence | Biopsy, glucocorticoid, intravenous immunoglobulin | Lymph nodes and bone marrow | Glucocorticoid and methotrexate |
27 | 18/M | Undiagnosed | – | Multiple intracranial lesions and lymph nodes | Cytarabine |
28 | 39/M | Undiagnosed | – | Multiple bone lesions and lymph nodes | Lenalidomide and glucocorticoid |